Press releases from FDA http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml en-us Tue, 22 May 2012 12:06:00 -0400 tina.gilliam@fda.hhs.gov A team of researchers led by the U.S. Food and Drug Administration has discovered a new mechanism for identifying and understanding drug-related autoimmune reactions. Tue, 22 May 2012 12:06:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm305067.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm305067.htm U.S. Marshals, acting at the request of the Food and Drug Administration, have seized HybriSil (methylprednisolone acetate 1% percentin silicone gel), an unapproved new drug marketed by Crescendo Therapeutics, L.L.C., of Vista, Calif. Tue, 22 May 2012 12:03:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm305006.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm305006.htm The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries. Thu, 17 May 2012 14:04:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm304489.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm304489.htm The U.S. Food and Drug Administration today expanded the use for the FilmArray Respiratory Panel, the first test that can simultaneously detect both viral and bacterial causes of respiratory infection from a single sample. Tue, 15 May 2012 13:29:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm304177.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm304177.htm The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation procedure” to treat chronic cerebrospinal venous insufficiency (CCSVI). Thu, 10 May 2012 08:58:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303538.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303538.htm Today, the U.S. Food and Drug Administration announced that it is seeking public comment on a proposal encouraging manufacturers to consider the safety of children in the design of new X-ray imaging devices. In the draft guidance, FDA is recommending that manufacturers design new X-ray imaging devices with protocols and instructions that address use on pediatric patients. Wed, 09 May 2012 09:00:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303386.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303386.htm The U.S. Food and Drug Administration issued its final rule on sterility testing, amending the requirements for most licensed biological products. Thu, 03 May 2012 13:52:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302844.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302844.htm On April 30, the U.S. Food and Drug Administration today allowed marketing of the first surgical instrument set that can be assembled and disassembled inside the body during surgery. The Percutaneous Surgical Set is intended to be used during minimally invasive laparoscopic abdominal surgery, in which a camera and surgical instruments are inserted through one or more small incisions (surgical cuts into body tissue) in the abdomen. Tue, 01 May 2012 17:52:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302561.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302561.htm The U.S. Food and Drug Administration today approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder. Tue, 01 May 2012 16:09:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302549.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302549.htm The U.S. Food and Drug Administration today approved Levaquin (levofloxacin) to treat patients with plague, a rare and potentially deadly bacterial infection. The agency also approved the drug to reduce the risk of getting plague after exposure to Yersinia pestis, the bacterium that causes the disease. Mon, 30 Apr 2012 09:24:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302220.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302220.htm The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction. Fri, 27 Apr 2012 13:47:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302140.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302140.htm The U.S. Food and Drug Administration today issued warning letters to ten manufacturers and distributors of dietary supplements containing dimethylamylamine, more popularly known as DMAA, for marketing products for which evidence of the safety of the product had not been submitted to FDA. Fri, 27 Apr 2012 14:56:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302133.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302133.htm The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue sarcoma is a cancer that begins in the muscle, fat, fibrous tissue, and other tissues. Thu, 26 Apr 2012 17:47:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302065.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302065.htm The U.S. Food and Drug Administration today approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex (TSC). Thu, 26 Apr 2012 16:33:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302048.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302048.htm This week, the U.S. Department of Agriculture (USDA) confirmed that a dairy cow in California tested positive for atypical bovine spongiform encephalopathy (BSE, or "mad cow" disease). The USDA also confirmed the cow did not enter the animal feed or human food supply. The U.S. Food and Drug Administration is working with federal and state authorities to further investigate this case. Thu, 26 Apr 2012 09:20:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301850.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301850.htm The U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D. today released the agency’s “Global Engagement Report” [INSERT HYPERLINK], detailing the many activities and strategies FDA is using to transform from a domestic to a global public health agency. Mon, 23 Apr 2012 08:54:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301191.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301191.htm A strengthened and modernized postmarket drug safety program has resulted in a substantial improvement in the U.S. Food and Drug Administration’s oversight of drugs once they reach the American public, according to a new report released today by the agency’s Center for Drug Evaluation and Research (CDER). The report, “Advances in FDA’s Safety Program for Marketed Drugs,” describes new scientific tools and enhanced capabilities that give the same priority to postmarket drug safety monitoring as to premarket drug review. Sat, 21 Apr 2012 13:03:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301165.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301165.htm Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration. Fri, 20 Apr 2012 13:24:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301125.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm301125.htm U.S. Marshals, acting at the request of the Food and Drug Administration, today seized Other-Sonic Generic Ultrasound Transmission Gel located at Pharmaceutical Innovations Inc. in Newark, N.J. after an FDA analysis found that product samples contained dangerous bacteria. Wed, 18 Apr 2012 13:50:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm300838.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm300838.htm • Moon Marine USA Corporation (also known as MMI) of Cupertino, Calif. is voluntarily recalling 58,828 lbs of a frozen raw yellowfin tuna product, labeled as Nakaochi Scrape AA or AAA. Nakaochi Scrape is tuna backmeat, which is specifically scraped off from the bones, and looks like a ground product. • The product is not available for sale to individual consumers, but may have been used to make sushi, sashimi, ceviche and similar dishes available in restaurants and grocery stores. • The company name and Nakaochi Scrape AA or AAA were printed on boxes of the product when it was initially sold to distributors. However, the boxes may have been broken into smaller lots for further sale and may not be available to the end retailer or consumer. Therefore, the tuna may not be readily identifiable by retail outlets or by consumers as being from the implicated lots. • The Nakaochi Scrape AA and AAA from MMI was sold through distributors to restaurants and grocery stores that make sushi, and has been linked to an outbreak of Salmonella Bareilly, which has caused 116 illnesses in 20 states and the District of Columbia to date. Of the reported illnesses, there have been 12 hospitalizations, and no deaths. • Many of the people who became ill reported eating raw tuna in sushi as “spicy tuna.” • If you purchase “spicy tuna” or other sushi, sashimi, ceviche, or similar dishes that might contain Nakaochi Scrape from a restaurant or grocery store, check with the establishment to make sure that it does not contain raw recalled product from Moon Marine USA Corporation, also known as MMI. When in doubt, don’t eat it. • Consumers who think they might have become ill from eating possibly contaminated raw Nakaochi Scrape should consult their health care providers. Fri, 13 Apr 2012 18:54:00 -0400 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm300397.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm300397.htm